Indomethacin reduces lung adenoma number in A/J mice

Anticancer Research

Volumn 21, Issue 3 B, 2001, Pages 1749-1755

  Moody, T W ^a   Leyton, J ^a   Zakowicz, H ^a   Hida, T ^a   Kang, Y ^a   Jakowlew, S ^a   You, L ^a   Ozbun, L ^a   Zia, H ^a   Youngberg, J ^a   Malkinson, A ^a  

^a Medicine Branch   (United States)

Author keywords

A J mice; Apoptosis; Cyclooxygenase; Indomethacin; Lung adenomas

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRONCHIOLE; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOSOL; FEMALE; FOLLOW UP; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOMA; LUNG ALVEOLUS CELL TYPE 2; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADENOMA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; BRONCHI; CARCINOGENS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOSOL; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; ISOENZYMES; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TUMOR CELLS, CULTURED; URETHANE;

EID: 0034909523     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Molecular Biology of lung cancer
2. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
3. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
4. Expression of epidermal growth factor receptor (EGF-R) in human lung tumours
5. Expression of the neu gene-encoded protein (P185neu) in human non-small cell caricomas of the lung
6. A VIP antagonist inhibits the growth of non-small cell lung cancer
7. Tumorigenesis and genotoxicity of ethyl carbamate and vinyl carbamate in rodent cells
8. Primary lung tumors in mice: An experimentally manipulable model of human adenocarcinoma
9. Comparative carcinogenecity in A/J mice and metabolism by cultured mouse peripheral lung of N'-nitrosonornicotine, 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues
10. Activation of the k-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse
11. Reduction on transforming growth factor-β type II receptor in mouse lung carcinogenesis
12. Chemoprevention efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice
13. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence
14. The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthase
15. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme
16. Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs
17. Suppression of intestinal polyposis in Apc 716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
18. Prostaglandin endoperoxide synthases
19. Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors
20. Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs
21. Laser capture microdissection
22. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
23. Human cyclooxygenase-2 cDNA
24. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non- small cell lung cancer
25. Mouse lung epithelial cell lines: Tools for the study of differentiation and the neoplastic phenotype
26. (Psi13,14) Bombesin analogues inhibit the growth of small cell lung cancer in vitro and in vivo
27. Inhibition of lung tumorigenesis by sulindac: Comparison of two experimental protocols
28. Reduced risk of large-bowel adenomas among aspirin users: The polyp prevention study group
29. Aspirin use and the risk for colorectal
30. Aspirin use and reduced risk of fatal colon cancer
31. Aspirin use and risk of fatal cancer
32. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: A novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach
33. NS-398 A novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions
34. Increased expression of cyclooxgenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
35. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro
36. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398
37. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2
38. Molecular pathology of cyclooxygenase-2 in neoplasia
39. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
40. Risin, Fan, Dong, Bielenber, Bucana, Fidler. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells
41. Mega base map of the epidermal growth factor (EGF) receptor gene flanking regions and structure of the amplification units in EGF receptor-hyper-producing squamous carcinoma cell
42. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor in human colorectal cancer cell lines
43. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
44. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
45. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms
46. Inhaled indomethacin in bronchorrhea in bronchioloalveolar carcinoma: Role of cyclooxygenase
47. COX 2-selective NSAIDs: Biology, promises and concerns